Kotak upgraded Clean Science to "Buy" with a revised target of ₹1,370 (from ₹1,380 earlier).

This follows a sharp 20% drop after the promoter-family stake sale of 24% concluded.

The improved risk-reward outlook reflects strong growth pipelines and cleaner governance.

Analysts find fundamentals remain intact despite temporary stock pressure.

Investors may now reconsider exposure to quality mid-cap opportunities.

Monitor trading volumes and price action in the coming sessions for confirmation.

Recommendation signals rebound potential amid broader market recovery.

The upgrade underscores structural strength over short-term disruptions.

This may trigger re-evaluation of similarly impacted mid-cap stocks.

Quality and clarity now guide tactical entry points.